12
Participants
Start Date
October 31, 2016
Primary Completion Date
December 31, 2017
Study Completion Date
September 30, 2018
ReCell
"The ReCell-assigned treatment area will be treated as described in the product's Instructions for Use. In summary, 1ml of fluid physically covers a treatment area of 80 cm2. Each milliliter of fluid contains cells harvested from a square centimeter of thin split-thickness skin sample.~The reagents and components of the ReCell kit are used, in a scalable fashion, to facilitate disaggregation of cells from skin samples into filtered cell suspension. Areas to be harvested for skin samples are to be clean and show no evidence of surrounding cellulitis or infection. Treatment area sizes and cell suspension volumes are to be recorded."
MedStar Washington Hospital Center, Washington D.C.
Wake Forest Baptist Medical Center, Winston-Salem
Tampa General Hospital, Tampa
Arizona Burn Center at Maricopa Integrated Health Systems, Phoenix
University of Tennessee Health Science Center, Memphis
U.S.Army Institute of Surgical Research, Fort Sam Houston
Lead Sponsor
Avita Medical
INDUSTRY